fingolimod hydrochloride has been researched along with sofosbuvir in 1 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (sofosbuvir) | Trials (sofosbuvir) | Recent Studies (post-2010) (sofosbuvir) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 2,164 | 318 | 2,064 |
Protein | Taxonomy | fingolimod hydrochloride (IC50) | sofosbuvir (IC50) |
---|---|---|---|
Cytochrome P450 3A4 | Homo sapiens (human) | 8.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dintsios, CM; Rasch, A | 1 |
1 review(s) available for fingolimod hydrochloride and sofosbuvir
Article | Year |
---|---|
[Subgroups in the early benefit assessment of pharmaceuticals: a methodical review].
Topics: Adenosine; Anilides; Axitinib; Drug Approval; Effect Modifier, Epidemiologic; Fingolimod Hydrochloride; Germany; Humans; Imidazoles; Indazoles; National Health Programs; Pyridines; Risk Assessment; Sitagliptin Phosphate; Sofosbuvir; Ticagrelor | 2015 |